Di Nuzzo Private Wealth, Inc. Biomarin Pharmaceutical Inc Transaction History
Di Nuzzo Private Wealth, Inc.
- $579 Million
- Q2 2024
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 21 shares of BMRN stock, worth $1,459. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21
Previous 18
16.67%
Holding current value
$1,459
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BMRN
# of Institutions
632Shares Held
185MCall Options Held
1.63MPut Options Held
1.2M-
Black Rock Inc. New York, NY22.7MShares$1.58 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.32 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA18.8MShares$1.31 Billion1.14% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$968 Million0.72% of portfolio
-
Capital Research Global Investors Los Angeles, CA9.69MShares$674 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.9B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...